The Phytopathological Disease Diagnostics market studied is anticipated to grow with a CAGR of nearly 4.4%, during the forecast period.
Certain factors that are driving the market growth include Benefits of rapid and accurate diagnosis of phytopathological diseases and Increasing prevalence of phytopathological disease.
Science and technology has made significant contributions to plant pathology by elucidating the general principles underlying the development of disease epidemics. This has resulted in a greatly improved theoretical and empirical understanding of the dynamics of disease epidemics in time and space, predictions of disease outbreaks or the need for disease control in real-time basis, and tactical and strategic solutions to disease problems.
Availability of high-resolution experimental data at multiple temporal and spatial scales has now provided a platform to test and validate theories on the spread of diseases at a wide range of spatial scales ranging from the local to the landscape level. Relatively new approaches in plant disease diagnostics, ranging from network to information theory, coupled with the availability of large-scale datasets and the rapid development of molecular biotechnology, are leading to revolutionary thinking about epidemics that can result in considerable improvement of strategic and tactical decision making in the control and management of plant diseases.
Key Market Trends
PCR-based Assays Holds Significant Share in the Global Phytopathological Disease Diagnostics Market
PCR-based molecular diagnostic tests are increasingly being used to guide phytopathological disease diagnostics. Globally, the prevalence of plant diseases, coupled with the increased availability of genetic and genomic information, is on the rise and it has led to the rapid incorporation of PCR techniques in clinical laboratories. The high specificity, sensitivity, and low sample requirement make PCR-based molecular assay a go-to technique for the purpose of clinical diagnosis. PCR-based molecular assays are becoming the primary mode of diagnosis for the detection of pathogens in case of a rapid disease outbreak. This trend is primarily due to the low or non-availability of rapid or specific diagnostic tests for several plant diseases. Pertaining to broad applications of PCR in the field of disease diagnostics, the market segment is likely to register high growth during the forecast period.
North America Dominates the Global Phytopathological Disease Diagnostics Market
The increasing prevalence of phytopathological disorders and favorable R&D initiatives, are the primary factors driving the growth of the market. The growth can also be attributed to the presence of sophisticated diagnostic laboratories and the high acceptance rate of novel assay technologies. There is a growing trend of genetic engineering and plant genomic research in academia and biotechnology industries of the United States. Increasing genomic research is primarily fueled by the high demand for targeted management of phytopathological disorders, as well as due to the need for understanding the genetic and molecular basis of plant disease. In recent years, several government initiatives were launched, which are supplementing the growth of the studied market.
The global Phytopathological Disease Diagnostics market is competitive and consists of a few major players. Companies like Abingdon Health, Agdia, Inc., BIOREBA AG, Creative Diagnostics, LOEWE Biochemica GmBH, Norgen Biotek Corp., Qualiplante SAS, TwistDx Limited, among others, hold the substantial market share in the market.
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
This product will be delivered within 2 business days.
Table of Contents
1.2 Study Assumptions
1.3 Scope of the Study
4.2 Market Drivers
4.2.1 Benefits of Rapid and Accurate Diagnosis of Phytopathological Diseases
4.2.2 Increasing Prevalence of Phytopathological Disease
4.3 Market Restraints
4.3.1 Lack of Skilled Personnel and Limited Knowledge About Plant Health
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1.2 Lateral Flow Devices
5.1.3 Accessories and Other Consumables
5.2 By Technology
5.2.1 PCR-based Assays
5.2.2 Serological Tests
5.2.3 Isothermal Amplification Assays
5.2.4 Other Technologies
5.3 By End-user
5.3.1 Academic and Research Institutes
5.3.2 Food Processing Laboratories
5.4.1 North America
5.4.4 Rest of the World
6.1.1 Abingdon Health
6.1.2 Agdia, Inc.
6.1.3 BIOREBA AG
6.1.4 Creative Diagnostics
6.1.5 LOEWE Biochemica GmBH
6.1.6 Norgen Biotek Corp.
6.1.7 Qualiplante SAS
6.1.8 TwistDx Limited
A selection of companies mentioned in this report includes:
- Abingdon Health
- Agdia, Inc.
- BIOREBA AG
- Creative Diagnostics
- LOEWE Biochemica GmBH
- Norgen Biotek Corp.
- Qualiplante SAS
- TwistDx Limited